Clinical Study of Ayurvedic Formulations in Managment of Anurjatajanya Shwas (Atopic asthma).

An Etiopathological study of Anurjatajanyajanya Shwas with special reference to Atopic asthma and Comparative Therapeutic Trial of Amritadi Kwath and Shunthyadi Churan.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051547

Enrollment

Registered

2023-04-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma Health Condition 2: J682- Upper respiratory inflammation dueto chemicals, gases, fumes and vapors, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Anurjatajanya shwasa w. s. r. to atopic asthma. Patients will be selected irrespective of sex, caste, occupation, socio- economic status.

Exclusion criteria

Exclusion criteria: 1. The patients suffering from malignant systemic disorders especially those are mentioned as asadhya vyadhi as per clinical text of Ayurveda will be excluded. 2. Patient having any Cardiac history as - cardiac asthma. 3. Patient having any history of other complicated respiratory diseases as â?? COPD, Pleural effusion, Pneumonia. 4. Patient having history of Atopic asthma with any other serious systemic disease like cerebrovascular, cardiovascular, hepatic disorder, renal disorder etc. 5. Pregnancy or lactating women. 6. Patients presents with co-morbid disorder (D.M., T.B., R.A., CARCINOMA etc.) 7. H/o hypersensitivity to the trial drug or any of its ingredients.

Design outcomes

Primary

Measure	Time frame
1. Etiopathogenesis of Anurjatajanya Shwasa w. s. r. to atopic asthma. 2. Therapeutic efficacy of Amritadi Kwath in Anurjatajanya Shwasa w. s. r. to atopic asthma. 3. Therapeutic efficacy of Shunthyadi Churna in Anurjatajanya Shwasa w. s. r. to atopic asthmaTimepoint: 2 month	—

Secondary

Measure	Time frame
1. Changes in clinical assessment criteria. 2. Changes in Ig E. 3. Changes in spirometry. 4. Changes in eosinophil count. Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Jagdish prasad kumawat

National institute of ayurveda deemed to be university

drsksm31@rediffmail.com9414361874

Outcome results